Inspire Medical Systems (INSP) has a ROE of 16.36%, below the Healthcare sector average of 21.67%.
Get informed when a big investor buys or sells
+ Follow16.36%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Inspire Medical Systems (INSP) currently reports a ROE of 16.36%. That is below the Healthcare sector average of 21.67%. Use the charts on this page to explore Inspire Medical Systems's ROE history and peer comparisons.
Inspire Medical Systems's ROE of 16.36% is lower than the Healthcare sector average of 21.67%. That is roughly 24.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Inspire Medical Systems's current 16.36% should be judged against Healthcare norms (sector average: 21.67%) and against INSP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 16.36%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Inspire Medical Systems, and consider following INSP for alerts when major investors trade the stock.
Inspire Medical Systems is classified in the Healthcare sector. On ROE, it currently shows 16.36% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INSP with unrelated industries.